NCT03024086View on ClinicalTrials.gov

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

April 25, 2017

Study Completion Date

April 25, 2017

Conditions
Functional Dyspepsia
Interventions
DRUG

DWJ1252

DWJ1252 and Placebo of Gasmotin

DRUG

Gasmotin

Gasmotin and Placebo of DWJ1252

Trial Locations (1)

Unknown

Hanyang University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY